{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:03:01Z","timestamp":1787068981810,"version":"build-2736575974"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T00:00:00Z","timestamp":1757116800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G077622N"],"award-info":[{"award-number":["G077622N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bone.2025.117623","type":"journal-article","created":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T06:43:41Z","timestamp":1757141021000},"page":"117623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Understanding the genetic basis of medication-related osteonecrosis of the jaw: A systematic review"],"prefix":"10.1016","volume":"201","author":[{"given":"Sonya","family":"Radi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah Sarah","family":"Jans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Moreno-Rabi\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Beuselinck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Cleynen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhilde","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2025.117623_bb0005","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2025.117623_bb0010","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/17843286.2017.1348001","article-title":"Incidence of osteonecrosis of the jaw in patients with bone metastases treated sequentially with bisphosphonates and denosumab","volume":"73","author":"Loyson","year":"2018","journal-title":"Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine"},{"key":"10.1016\/j.bone.2025.117623_bb0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and Management of Osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2025.117623_bb0020","first-page":"869","article-title":"Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors","volume":"26","author":"van Cann","year":"2018","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.bone.2025.117623_bb0025","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.3390\/diagnostics13132137","article-title":"Medication-related osteonecrosis of the jaws: a comparison of SICMF\u2013SIPMO and AAOMS Guidelines","volume":"13","author":"De Cicco","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.bone.2025.117623_bb0030","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons\u2019 position paper on medication-related osteonecrosis of the Jaws-2022 update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2025.117623_bb0035","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.coms.2015.06.001","article-title":"Pathophysiology of osteonecrosis of the jaws","volume":"27","author":"Aghaloo","year":"2015","journal-title":"Oral Maxillofac. Surg. Clin. North Am."},{"key":"10.1016\/j.bone.2025.117623_bb0040","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s11914-018-0474-4","article-title":"Current understanding of the pathophysiology of osteonecrosis of the jaw","volume":"16","author":"Chang","year":"2018","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.bone.2025.117623_bb0045","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ijom.2019.07.016","article-title":"Pharmacogenetics of medication-related osteonecrosis of the jaw: a systematic review and meta-analysis","volume":"49","author":"Guo","year":"2020","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2025.117623_bb0050","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.ijom.2019.04.014","article-title":"Genetic predisposition for medication-related osteonecrosis of the jaws: a systematic review","volume":"48","author":"Pereira","year":"2019","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2025.117623_bb0055","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/agm2.12347","article-title":"The increasing prevalence of cancer in the elderly: an investigation of epidemiological trends","volume":"7","author":"Prathap","year":"2024","journal-title":"Aging Medicine"},{"key":"10.1016\/j.bone.2025.117623_bb0060","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1186\/s13018-021-02821-8","article-title":"Global prevalence of osteoporosis among the world older adults: a comprehensive systematic review and meta-analysis","volume":"16","author":"Salari","year":"2021","journal-title":"J. Orthop. Surg. Res."},{"key":"10.1016\/j.bone.2025.117623_bb0065","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/annonc\/mdm442","article-title":"Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel","volume":"19","author":"Aapro","year":"2008","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bone.2025.117623_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10785","article-title":"Pathophysiology of medication-related osteonecrosis of the jaw-a Minireview","volume":"7","author":"Tetradis","year":"2023","journal-title":"JBMR Plus"},{"key":"10.1016\/j.bone.2025.117623_bb0075","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1601-0825.2012.01912.x","article-title":"New approach to analyze genetic and clinical data in bisphosphonate-induced osteonecrosis of the jaw","volume":"18","author":"Balla","year":"2012","journal-title":"Oral Dis."},{"key":"10.1016\/j.bone.2025.117623_bb0080","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s12967-019-2129-3","article-title":"Identifying genetic variants underlying medication-induced osteonecrosis of the jaw in cancer and osteoporosis: a case control study","volume":"17","author":"Lee","year":"2019","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bone.2025.117623_bb0085","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12903-021-01634-9","article-title":"Medication-related osteonecrosis of the jaw (MRONJ) and eNOS polymorphisms in multiple myeloma patients: a single center experience","volume":"21","author":"Ta\u015f Ozyurtseven","year":"2021","journal-title":"BMC Oral Health"},{"key":"10.1016\/j.bone.2025.117623_bb0090","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.3390\/jcm11082145","article-title":"Identification of potentially pathogenic variants associated with recurrence in medication-related osteonecrosis of the jaw (MRONJ) patients using whole-exome sequencing","volume":"11","author":"Kim","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bone.2025.117623_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcms.2024.06.007","article-title":"Examination of certain single-nucleotide polymorphisms of interleukins 1A and 1B in medication-related osteonecrosis of the jaw \u2014 an ambirectional cohort study","author":"Szentpeteri","year":"2024","journal-title":"J. Craniomaxillofac. Surg."},{"key":"10.1016\/j.bone.2025.117623_bb0100","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1182\/blood-2008-04-147884","article-title":"Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis","volume":"112","author":"Sarasquete","year":"2008","journal-title":"Blood"},{"issue":"579","key":"10.1016\/j.bone.2025.117623_bb0105","article-title":"A SNP in CYP2C8 is not associated with the development of bisphosphonate-related osteonecrosis of the jaw in men with castrate-resistant prostate cancer","volume":"6","author":"Sissung","year":"2010","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.bone.2025.117623_bb0110","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ijom.2011.02.002","article-title":"Genetic polymorphisms and other risk factors associated with bisphosphonate induced osteonecrosis of the jaw","volume":"40","author":"Katz","year":"2011","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2025.117623_bb0115","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2141.2011.08622.x","article-title":"A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profiling","volume":"154","author":"Di Martino","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bone.2025.117623_bb0120","first-page":"251","article-title":"Pharmacogenetics of bisphosphonate-associated osteonecrosis of the jaw","volume":"E3","author":"Marini","year":"2011","journal-title":"Front. Biosci."},{"key":"10.1016\/j.bone.2025.117623_bb0125","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2217\/bmm.12.14","article-title":"An aromatase polymorphism (g.132810C>T) predicts risk of bisphosphonate-related osteonecrosis of the jaw","volume":"6","author":"La Ferla","year":"2012","journal-title":"Biomark. Med."},{"key":"10.1016\/j.bone.2025.117623_bb0130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jcms.2012.10.018","article-title":"Major histocompatibility complex class II polymorphisms are associated with the development of anti-resorptive agent-induced osteonecrosis of the jaw","volume":"41","author":"Stockmann","year":"2013","journal-title":"J. Craniomaxillofac. Surg."},{"key":"10.1016\/j.bone.2025.117623_bb0135","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/odi.12355","article-title":"Genetic association between VEGF polymorphisms and BRONJ in the Korean population","volume":"21","author":"Choi","year":"2015","journal-title":"Oral Dis."},{"key":"10.1016\/j.bone.2025.117623_bb0140","article-title":"Prediction of medication-related osteonecrosis of the jaws using machine learning methods from estrogen receptor 1 polymorphisms and clinical information","volume":"10","author":"Choi","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.bone.2025.117623_bb0145","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1080\/10428194.2017.1300889","article-title":"Genetic factors related with early onset of osteonecrosis of the jaw in patients with multiple myeloma under zoledronic acid therapy","volume":"58","author":"Kastritis","year":"2017","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.bone.2025.117623_bb0150","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/jbmr.4185","article-title":"SIRT1 gene SNP rs932658 is associated with medication-related osteonecrosis of the jaw","volume":"36","author":"Yang","year":"2021","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2025.117623_bb0155","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/jbmr.3285","article-title":"SIRT1\/HERC4 locus associated with bisphosphonate-induced osteonecrosis of the jaw: an exome-wide association analysis","volume":"33","author":"Yang","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2025.117623_bb0160","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav9166","article-title":"ATRAID regulates the action of nitrogen-containing bisphosphonates on bone","volume":"12","author":"Surface","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bone.2025.117623_bb0165","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3390\/ph16071035","article-title":"Interactive associations between PPAR\u03b3 and PPARGC1A and bisphosphonate-related osteonecrosis of the jaw in patients with osteoporosis","volume":"16","author":"Kim","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bone.2025.117623_bb0170","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3390\/jpm11060541","article-title":"Machine learning approaches for predicting bisphosphonate-related osteonecrosis in women with osteoporosis using VEGFA gene polymorphisms","volume":"11","author":"Kim","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.bone.2025.117623_bb0175","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/odi.13746","article-title":"Osteonecrosis of the jaw risk factors in bisphosphonate-treated patients with metastatic cancer","volume":"28","author":"Van Poznak","year":"2022","journal-title":"Oral Dis."},{"key":"10.1016\/j.bone.2025.117623_bb0180","article-title":"Genome-wide association study of osteonecrosis of the jaw in Danish patients receiving antiresorptive therapy for osteoporosis: a case-control study","volume":"18","author":"Pedersen","year":"2023","journal-title":"Bone Rep"},{"key":"10.1016\/j.bone.2025.117623_bb0185","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.3390\/ijms25073646","article-title":"Analysis of SIRT1 gene SNPs and clinical characteristics in medication-related osteonecrosis of the jaw","volume":"25","author":"Bojtor","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bone.2025.117623_bb0190","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1002\/cpt.2397","article-title":"Genome-wide association study identified chromosome 8 locus associated with medication-related osteonecrosis of the jaw","volume":"110","author":"Yang","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bone.2025.117623_bb0195","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.3324\/haematol.2011.042572","article-title":"CYP2C8 gene polymorphism and bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma","volume":"96","author":"Such","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.bone.2025.117623_bb0200","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1600-0714.2010.01004.x","article-title":"Vascular endothelial growth factor genetic polymorphisms and haplotypes in female patients with bisphosphonate-related osteonecrosis of the jaws","volume":"40","author":"Arduino","year":"2011","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.bone.2025.117623_bb0205","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1634\/theoncologist.2011-0202","article-title":"Genomewide pharmacogenetics of bisphosphonate-induced osteonecrosis of the jaw: the role of RBMS3","volume":"17","author":"Nicoletti","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.bone.2025.117623_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1015128","article-title":"Complement C1s as a diagnostic marker and therapeutic target: progress and propective","volume":"13","author":"Ye","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bone.2025.117623_bb0215","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9710376","article-title":"Human leukocyte antigen (HLA) system: genetics and association with bacterial and viral infections","volume":"2022","author":"Medhasi","year":"2022","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.bone.2025.117623_bb0220","doi-asserted-by":"crossref","DOI":"10.15761\/OHC.1000194","article-title":"Streptococcal infection complications in laryngology and dentistry-review","volume":"5","author":"Michalik","year":"2020","journal-title":"Oral Health and Care"},{"key":"10.1016\/j.bone.2025.117623_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00620","article-title":"Mast cell: A multi-functional master cell","volume":"6","author":"Krystel-Whittemore","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bone.2025.117623_bb0230","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1261\/rna.078729.121","article-title":"Regulation and functional consequences of mGlu4 RNA editing","volume":"27","author":"Hofmann","year":"2021","journal-title":"RNA"},{"key":"10.1016\/j.bone.2025.117623_bb0235","article-title":"Glutamate signaling in bone","volume":"3","author":"Brakspear","year":"2012","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.bone.2025.117623_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-15586-0","article-title":"FAM19A5, a brain-specific chemokine, inhibits RANKL-induced osteoclast formation through formyl peptide receptor 2","volume":"7","author":"Park","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.bone.2025.117623_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000808","article-title":"Characterization of a family of novel cysteine- serine-rich nuclear proteins (CSRNP)","volume":"2","author":"Gingras","year":"2007","journal-title":"PloS One"},{"key":"10.1016\/j.bone.2025.117623_bb0250","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cell.2016.11.042","article-title":"Prohibitin 2 is an inner mitochondrial membrane Mitophagy receptor","volume":"168","author":"Wei","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bone.2025.117623_bb0255","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.mce.2015.01.016","article-title":"Estrogen receptor alpha phosphorylation and its functional impact in human breast cancer","volume":"418","author":"Anbalagan","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bone.2025.117623_bb0260","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1007\/s00018-013-1317-1","article-title":"The role of estrogen receptor \u03b1 in the regulation of bone and growth plate cartilage","volume":"70","author":"B\u00f6rjesson","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bone.2025.117623_bb0265","article-title":"TBCK influences cell proliferation, cell size and mTOR signaling pathway","volume":"8","author":"Liu","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.bone.2025.117623_bb0270","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.steroids.2014.12.010","article-title":"Estrogen and bone health in men and women","volume":"99","author":"Cauley","year":"2015","journal-title":"Steroids"},{"key":"10.1016\/j.bone.2025.117623_bb0275","doi-asserted-by":"crossref","first-page":"e00410","DOI":"10.1128\/iai.00410-24","article-title":"Estrogen prevented gingival barrier injury from Porphyromonas gingivalis lipopolysaccharide","volume":"93","author":"Huang","year":"2025","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bone.2025.117623_bb0280","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/jicd.12047","article-title":"Association of bone mineral density with periodontal status in postmenopausal women","volume":"5","author":"Singh","year":"2014","journal-title":"J. Investig. Clin. Dent."},{"key":"10.1016\/j.bone.2025.117623_bb0285","doi-asserted-by":"crossref","first-page":"5979","DOI":"10.1038\/s41388-020-01410-z","article-title":"IMPAD1 and KDELR2 drive invasion and metastasis by enhancing Golgi-mediated secretion","volume":"39","author":"Bajaj","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.bone.2025.117623_bb0290","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1152\/advan.00052.2006","article-title":"PGC-1alpha: a key regulator of energy metabolism","volume":"30","author":"Liang","year":"2006","journal-title":"Adv. Physiol. Educ."},{"key":"10.1016\/j.bone.2025.117623_bb0295","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00223-021-00899-0","article-title":"Adipose tissue dysfunction: impact on bone and Osseointegration","volume":"110","author":"King","year":"2022","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2025.117623_bb0300","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/02763869.2019.1588072","article-title":"PROSPERO: an international register of systematic review protocols","volume":"38","author":"Schiavo","year":"2019","journal-title":"Med. Ref. Serv. Q."},{"key":"10.1016\/j.bone.2025.117623_bb0305","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.bone.2025.117623_bb0310","series-title":"Covidence - Better systematic review management","year":"2014"},{"key":"10.1016\/j.bone.2025.117623_bb0315","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bone.2025.117623_bb0320","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1093\/bioinformatics\/btv402","article-title":"LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants","volume":"31","author":"Machiela","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bone.2025.117623_bb0325","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","article-title":"ShinyGO: a graphical gene-set enrichment tool for animals and plants","volume":"36","author":"Ge","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bone.2025.117623_bb0330","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12863-015-0211-2","article-title":"Assessing the quality of published genetic association studies in meta-analyses: the quality of genetic studies (Q-genie) tool","volume":"16","author":"Sohani","year":"2015","journal-title":"BMC Genet."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328225002352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328225002352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T07:58:47Z","timestamp":1780300727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328225002352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":66,"alternative-id":["S8756328225002352"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2025.117623","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding the genetic basis of medication-related osteonecrosis of the jaw: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2025.117623","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117623"}}